thyssenkrupp nucera AG & Co. KGaA stock: fair value
NCH2.DEThe fair value of thyssenkrupp nucera AG & Co. KGaA under our model is $2.54, the price is 253% above.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Significantly overvaluedIn our model the price counts as cheap below $1.95 and expensive above $3.63 (uncertainty medium, based on the price swings of the past year).
Calculated with a cost of equity of 7.1%. At 8.1% the fair value would be $2.15, at 6.1% it would be $3.13.
Where the number comes from
From the cash-flow model alone; without earnings there is no industry value.
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 2.1%. Discounted at 7.1% (floor: government bond yield 2.1% plus 5 percentage points, since beta 1.01 times the risk premium would give less); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $2.54 per share: free cash flow for the next ten years, each year discounted to today at 7.1%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 7.1%) |
|---|---|---|---|---|
| 2026 | $26.57M | extrapolated at −23.5% | 0.9334 | $24.8M |
| 2027 | $22.37M | extrapolated at −15.8% | 0.8712 | $19.49M |
| 2028 | $20.04M | extrapolated at −10.4% | 0.8131 | $16.3M |
| 2029 | $18.71M | extrapolated at −6.7% | 0.7589 | $14.2M |
| 2030 | $17.96M | extrapolated at −4.0% | 0.7083 | $12.72M |
| 2031 | $17.57M | extrapolated at −2.2% | 0.6611 | $11.62M |
| 2032 | $17.42M | extrapolated at −0.9% | 0.6171 | $10.75M |
| 2033 | $17.42M | extrapolated at 0.0% | 0.5760 | $10.03M |
| 2034 | $17.54M | extrapolated at 0.7% | 0.5376 | $9.43M |
| 2035 | $17.73M | extrapolated at 1.1% | 0.5017 | $8.9M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $138.22M |
| Terminal value: cash flow 2035 × (1 + 2.1%) / (7.1% − 2.1%) | $362.19M |
| Present value of terminal value (× 0.5017) | $181.73M |
| Equity value (sum plus present value of terminal value) | $319.94M |
| Shares (diluted) | 126.00M |
| Value per share (equity value divided by shares) | $2.54 |
| Fair value (from the cash flow model alone) | $2.54 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 30 Sep 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 17 Oct 2025)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.